Real Housewives of New Jersey -star Dolores Catania was one of the first harvest of celebrities that openly and unabashedly admitted to use Ozempic or a similar medicine to lose weight.
Now, after taking two years and going to her high school weight, Mrs. Catania said: “I know it's time to avert myself or go a lower dose.”
The reality star takes Mounjaro, a medicine similar to Ozempic, which contains the active ingredient Tirzepatide that mimics hormones in the brain responsible for regulating appetite and feelings of fullness.
Mrs. Catania weighed 157 pounds when she started medication two years ago, starting with Ozempic and transition to Mounjaro. Since then she has lost at least 30 pounds.
She warned that everyone who is considering the medicines should always go through a real doctor, although who knows what they are doing.
“Research is everything.”
Many people who would like to try groundbreaking obesity medicine believe that their insurance plans will not cover the costs, which can be a high $ 1,200 per month. In that case they often switch to online prescription platforms with a short medical professional consultation.
The drug usually comes from a composite pharmacy, where pharmacists mix it by hand with the help of its most important ingredients. The FDA does not control this practice, so unfair or inattentive practitioners can use defective ingredients or incorrect doses.
2024 US 2018: The 53-year-old reality star has dropped more than 20 pounds thanks to the Drugsmounjaro
Mrs. Catania told Hello! That the medicine has been 'a change of life' for her and her friend Paul Connell, who has lost 60 pounds.
She added: 'He no longer takes a certain blood pressure medication and it was really positive. There are side effects such as nausea, but you take a pill for that. '
Clinical examinations showed that people who take Mounjaro could expect to lose about 15 to 20 percent of their body weight for around 72 weeks. The drug works best when it is taken with a healthy diet and the training regime.
Mrs. Catania shared that she was 'a big carbohydrate person'.
“I was Doritos, chips, unity dip. Now it makes me nauseous. I absolutely don't eat that anymore. '
She and her friend also train three to four times a week and although it can be difficult to get herself moving, she said, “It is starting to feel good.”
Ozempic has been designed and approved to treat type 2 diabetes, but has been prescribed off-label for obesity for years. Mounjaro was approved to do the same, but was prescribed in the same way to stimulate weight loss.
Much loved by celebrities, the drugs became long -term deficits until only last fall, because people who would not necessarily benefit medically brought stocks as soon as they became available.
Mounjaro contains the active ingredient tirzepatide that mimics hormones in the brain responsible for regulating appetite and feelings of fullness.
For many body position influences, the meteorical increase in drugs in popularity turned around a slow, many years of social shift to body acceptance. It also led to anger towards celebrities for what many saw as jumping on the Dunness Bandwagon.
Mrs. Catania said, “I think I broke the seal to be honest about it.”
She was also quick to tell people that, instead of the drug to take vanity reasons, she had a medical need: 'I go through the menopause, I have a thyroid problem, I have inflammation and weight is difficult to get up to rise .
“And I train, and I don't eat crazy and I arrived, and they are many different layers.”
Doctors often warn people that these drugs are very effective tools for weight management, but they are not a magical bullet for obesity.
Dr. Amy Lee, Chief Medical Officer at Lindora Clinic, a company for weight control in South California, said: 'You will acquire the symptoms of hunger and desires you had before you started the medication. Your body will return to the “baseline”. '
A study from 2023 followed 670 people who took Tirzepatide for 36 weeks. At that time, people lost an average of 20 percent of their body weight.
After that, half of the participants continued to take a high dose of tirzepatide for another year, while the other half received a placebo injection. Both groups also received lifestyle counseling, aimed at reduced calorie -intake and regular exercise.
The group that continued Tirzepatide lost on average an extra 5.5 percent of their body weight, while those who switched to the placebo recover 14 percent of their weight.
The placebo group also showed elevated cholesterol, blood sugar and blood pressure levels compared to when they were on tirzepatide, according to Dr. Louis Aronne, main author of the study and director of the Comprehensive Weight Control Center at Weill Cornell Medicine.
